<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00459485</url>
  </required_header>
  <id_info>
    <org_study_id>200714985</org_study_id>
    <secondary_id>SerumZinc</secondary_id>
    <nct_id>NCT00459485</nct_id>
  </id_info>
  <brief_title>Effects of Initiation and Discontinuation of Short Term Zinc Supplementation on Plasma Zinc Concentration</brief_title>
  <official_title>Effects of Initiation and Discontinuation of Short Term Zinc Supplementation on the Magnitude and Velocity of Change in Plasma Zinc Concentration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>USDA, Western Human Nutrition Research Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a double-blind, randomized controlled trial conducted in men 19-65 years of age who
      will receive daily zinc supplements (10 or 20 mg zinc/d as zinc sulfate) or placebo for 21
      days. Blood samples for plasma zinc and CRP concentrations will be drawn at baseline and days
      1, 2, 5, 9, 14, and 21 during supplementation and days 1, 2, 5, 9, and 14 after
      discontinuation of supplementation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be a double blind, randomized, placebo controlled trial conducted in men 19-65
      years of age. Participants will receive daily zinc or placebo liquid supplements for 21 days.
      Supplemental zinc will be given as zinc sulfate; the lower dose zinc supplement will contain
      10 mg/d elemental zinc, and the higher dose zinc supplement will contain 20 mg/d elemental
      zinc. The placebo will contain the same excipients expect for zinc sulfate.

      Multiple blood draws will be performed throughout the course of the study, to determine the
      responsiveness of plasma zinc concentrations to zinc supplementation. Two baseline blood
      draws will occur prior to the start of supplementation (study days -7 and 0). Blood draws
      will be performed on days 1, 2, 5, 9, 14 and 21 of the 21 day supplementation period. Upon
      termination of supplementation (day 21), blood draws will be performed on days 1, 2, 5, 9, 14
      and 21 post-supplementation (study days 22, 23, 26, 30, 35 and 42).

      The major outcomes of interest are the magnitude and velocity of change in plasma zinc
      concentration. Other outcomes to be assessed are plasma concentrations of the acute phase
      proteins CRP and AGP, as well as reported morbidity, because of their potential roles as
      confounding variables. Anthropometric variables will be assessed at baseline.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma zinc concentration</measure>
    <time_frame>3 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">58</enrollment>
  <condition>Zinc Deficiency</condition>
  <arm_group>
    <arm_group_label>Zinc supplement (20 mg)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily intake of 20 mg supplementary zinc</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Zinc supplement (10 mg)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily intake of 10 mg supplementary zinc</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo supplement</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Daily intake of placebo supplement</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>zinc sulfate</intervention_name>
    <description>20 or 10 mg zinc per day for 3 weeks</description>
    <arm_group_label>Zinc supplement (20 mg)</arm_group_label>
    <arm_group_label>Zinc supplement (10 mg)</arm_group_label>
    <other_name>Producer: UCD pharmacy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Daily placebo for 3 weeks</description>
    <arm_group_label>Placebo supplement</arm_group_label>
    <other_name>Producer: UCD pharmacy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Generally health men

          -  19-65 years

          -  Non-anemic

        Exclusion Criteria:

          -  Age &lt;19 or &gt;65

          -  Hemoglobin &lt;120 g/L

          -  Clinical evidence of illness

          -  Consumption of mineral supplements

          -  Recent blood donation (within 8 weeks)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth H Brown, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2007</study_first_submitted>
  <study_first_submitted_qc>April 11, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2007</study_first_posted>
  <last_update_submitted>February 18, 2010</last_update_submitted>
  <last_update_submitted_qc>February 18, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2010</last_update_posted>
  <responsible_party>
    <name_title>Kenneth Brown</name_title>
    <organization>University of California</organization>
  </responsible_party>
  <keyword>Plasm zinc concentration</keyword>
  <keyword>Zinc supplementation</keyword>
  <keyword>Assessment of zinc status</keyword>
  <keyword>Plasma zinc concentration</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zinc</mesh_term>
    <mesh_term>Zinc Sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

